Literature DB >> 21750632

Renal anomalies associated with ectopic neurohypophysis.

Samim Özen1, Damla Gökşen Şişmek, Asan Önder, Şükran Darcan.   

Abstract

OBJECTIVE: Although the etiology of ectopic neurohypophysis that leads to pituitary hormone deficiencies is not yet clearly understood, birth trauma or genetic factors have been considered responsible. Concurrent cranial and extracranial congenital anomalies have been reported in such cases. The aim of the present study was to investigate the frequency of renal anomalies in nonsyndromic cases with ectopic neurohypophysis.
METHODS: We retrospectively evaluated the medical records of 20 patients with ectopic neurohypophysis who were followed up between January 1990 and December 2007 in a tertiary University Hospital.
RESULTS: Renal anomalies were identified in three (15%) cases including unilateral renal agenesis in one case, renal hypoplasia in one case, and double collecting system and unilateral renal agenesis in one case.
CONCLUSIONS: In the present study, the increased frequency of renal anomalies in cases of ectopic neurohypophysis was highlighted, and it was emphasized that there might be common genetic factors that lead to such associations. ©Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing.

Entities:  

Keywords:  Ectopic neurohypophysis; pituitary hormone deficiency; renal anomalies

Mesh:

Substances:

Year:  2011        PMID: 21750632      PMCID: PMC3119441          DOI: 10.4274/jcrpe.v3i2.12

Source DB:  PubMed          Journal:  J Clin Res Pediatr Endocrinol


INTRODUCTION

Ectopic neurohypophysis is frequently associated with anterior pituitary hormone deficiencies. Isolated growth hormone deficiency (GHD) or multiple pituitary hormone deficiency (MPHD), in which GHD is associated with one or more other anterior pituitary hormone deficiencies, may develop in these cases. Although the etiology is unclear, traumatic birth, breech delivery and genetic factors have all been considered as possible factors (1,2). Some of the genetic factors include LHX4, HESX1, GLI2, GH-1, GH releasing hormone (GHRH) receptor, POU1F1, PROP-1and SOX3 mutations and have been shown to be important in the development of the pituitary gland. However, studies have failed to implicate a genetic factor in 95% of cases of ectopic neurohypophysis associated with GHD (1,2,3,4,5). In the present study, nonsyndromic cases with ectopic neurohypophysis were evaluated with respect to renal developmental anomalies, while the etiology of GHD was being investigated.

MATERIALS AND METHODS

Patients Two-hundred and thirteen cases followed between January 1990 and December 2007 at the Pediatric Endocrinology Department of Ege University Faculty of Medicine with the diagnosis of GHD were included in this study. The medical records of the patients were retrospectively evaluated. Of the total group, 20 (9.3%) cases (7 girls and 13 boys), in whom ectopic neurohypophysis was detected via magnetic resonance imaging (MRI), were included in this study. We analyzed the data regarding chronologic age at the time of diagnosis, standard deviation scores (SDSs) for height and body mass index (BMI) at the time of diagnosis, history of parental consanguinity, difficult birth history, family history of short stature, presence of other pituitary hormone deficiencies or additional anomalies other than ectopic neurohypophysis and presence of renal anomalies. Sagittal and coronal 3-mm-thick slices of the pituitary area were obtained via MRI. All MRI scans were assessed by pediatric neuroradiologists who were not blinded to the clinical information. Two standard GH stimulation tests were performed with insulin and levodopa (L-DOPA). In one neonate, plasma GH levels were measured during spontaneous hypoglycemia. A peak value of less than 10 ng/mL in two tests was regarded as confirmatory for the diagnosis of GHD. Adrenocorticotropic hormone (ACTH) deficiency was diagnosed based on a cortisol level of less than 5 μg/dL and a peak cortisol level of less than 25 μg/dL on ACTH test. The diagnosis of thyroid-stimulating hormone (TSH) deficiency was based on a free thyroxine (fT4) level of less than 0.8 ng/dL in combination with a normal TSH level. Moreover, patients with TSH levels below the normal range were also diagnosed as having TSH deficiency. Thyrotropin-releasing hormone (TRH) stimulation test (7 μg/kg) was also used in the diagnosis of TSH deficiency. Hypogonadotropic hypogonadism was suspected when both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) responses to LH-releasing hormone (LHRH) stimulation test (100 μg/m2) were flat in pubertal patients. Basal and stimulated levels of cortisol, ACTH, TSH, prolactin (PRL), FSH, and LH were measured at sequential time points (15, 30, 60 and 90 minute after stimulation). Each hormone was measured by immunochemiluminescent assay and radioluminescence. Renal anomalies were examined by experienced radiologists via ultrasonography (US). In case of pathological findings on US, the presence of renal anomalies was confirmed via renal scintigraphy and intravenous pyelography (IVP). This study was conducted according to the principles of the Declaration of Helsinki.

RESULTS

The mean age of the patients at the time of diagnosis was 11.3±4.7 years (range, 0.2-18.1 years). The mean SDS for height at the time of diagnosis was -4.2±1.5 and the mean SDS for BMI at the time of diagnosis was -0.2±1.2. Five (20%) of the cases had a family history of short stature and two (10%) had a history of parental consanguinity. Two cases had a history of difficult birth. Endocrinological evaluation of the patients, in whom ectopic neurohypophysis was detected on MRI, revealed that five (20%) cases had isolated GHD and 15 (80%) had MPHD. GHD was followed by TSH deficiency (13/20; 65%), FSH-LH deficiency (9/20; 45%) and ACTH deficiency (4/20; 20%), in decreasing order. MRI scans revealed stalk formation in three cases. One of these cases had isolated GHD and two had MPHD. MPHD was determined in all of the 17 cases without stalk formation on MRI. Examination of the patients for renal anomalies revealed renal anomalies in three (15%) cases: unilateral renal agenesis in one case, renal hypoplasia in one case, and double collecting system and unilateral renal agenesis in one case. All of the cases with renal anomalies had also MPHD. Two patients had testicular hypoplasia, one case had chromosomal abnormality [46, XX/47, XX + mar (6) karyotype], and one case had Fanconi anemia. Table 1 shows the clinical characteristics, endocrinological deficiencies of the patients as well as the presence of renal and additional anomalies. None of the patients had a family history of renal anomalies.
Table 1

Clinical features, endocrinological deficiencies, renal and other additional anomalies of the patients

  24 in total

Review 1.  Transcription factors in pituitary gland development and their clinical impact on phenotype.

Authors:  P E Mullis
Journal:  Horm Res       Date:  2000

2.  Familial Kallmann syndrome with unilateral renal aplasia.

Authors:  J D Wegenke; D T Uehling; J B Wear; E S Gordon; J G Bargman; J S Deacon; J P Herrmann; J M Opitz
Journal:  Clin Genet       Date:  1975 May-Jun       Impact factor: 4.438

3.  Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

Authors:  P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

4.  Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4.

Authors:  K Machinis; J Pantel; I Netchine; J Léger; O J Camand; M L Sobrier; F Dastot-Le Moal; P Duquesnoy; M Abitbol; P Czernichow; S Amselem
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

5.  Arthrogryposis multiplex congenita and pituitary ectopia. A case report.

Authors:  E Parano; R R Trifiletti; R Barone; V Pavone; P Pavone
Journal:  Neuropediatrics       Date:  2000-12       Impact factor: 1.947

6.  Laterality disturbance and hypopituitarism. A case report of co-existing situs inversus totalis and combined pituitary hormone deficiency.

Authors:  Z Halász; R Bertalan; J Toke; A Patócs; M Tóth; G Fekete; E Gláz; K Rácz
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

7.  A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction.

Authors:  Luciani R Carvalho; Kathryn S Woods; Berenice B Mendonca; Nathalie Marcal; Andrea L Zamparini; Stefano Stifani; Joshua M Brickman; Ivo J P Arnhold; Mehul T Dattani
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Six1 is required for the early organogenesis of mammalian kidney.

Authors:  Pin-Xian Xu; Weiming Zheng; Li Huang; Pascal Maire; Christine Laclef; Derek Silvius
Journal:  Development       Date:  2003-07       Impact factor: 6.868

9.  Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.

Authors:  Erich Roessler; Yang-Zhu Du; Jose L Mullor; Esther Casas; William P Allen; Gabriele Gillessen-Kaesbach; Elizabeth R Roeder; Jeffrey E Ming; Ariel Ruiz i Altaba; Maximilian Muenke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

10.  Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development.

Authors:  R Nishinakamura; Y Matsumoto; K Nakao; K Nakamura; A Sato; N G Copeland; D J Gilbert; N A Jenkins; S Scully; D L Lacey; M Katsuki; M Asashima; T Yokota
Journal:  Development       Date:  2001-08       Impact factor: 6.868

View more
  1 in total

1.  International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors.

Authors:  Taryn Youngstein; Patrycja Hoffmann; Ahmet Gül; Thirusha Lane; Rene Williams; Dorota M Rowczenio; Huri Ozdogan; Serdal Ugurlu; John Ryan; Len Harty; Sean Riminton; Alex P Headley; Joachim Roesler; Norbert Blank; Jasmin B Kuemmerle-Deschner; Anna Simon; Adrian S Woolf; Philip N Hawkins; Helen J Lachmann
Journal:  Rheumatology (Oxford)       Date:  2017-12-01       Impact factor: 7.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.